Tris launches promethazine and codeine syrupThe drug’s market size was for the 12 months ended December 2017 was roughly $8 million, according to IQVIA data. FDA approves Lupin's generic Topicort sprayThe product had U.S. sales of roughly $19.5 million for the 12 months ended January 2018, according to IQVIA data. Mayne Pharma intros generic Monodox The product had U.S. sales of $30 million for the 12 months ended January 2018. FDA clears Strides Pharma’s generic Sustiva The product has a roughly $115 million market size, according to IQVIA data. Lupin intros Tydemi, its Safyral generic The product had U.S. sales of roughly $22 million for the 12 months ended January 2018. Amneal's erythromycin tablets launch Amneal's tablets are sold in 100-count bottles of 25- and 50-mg dosage strength tablets. Amneal launches generic Gabitril The product had a market size of roughly $30 million for the 12 months ended January 2018, according to IQVIA data. FDA clears first 2 generics of Sensipar The generic Sensipar tablets — from Aurobindo and Cipla — mark the ninth and 10th approvals this year of first-time generics from the FDA. CVS Health shares efforts to address drug costs at AHIP conference The company’s efforts include a new program that offers drug cost transparency for patients, pharmacists and prescribers. Camber intros generic Tamiflu capsules Camber’s generic Tamiflu capsules will be available in 30-, 45- and 75-mg dosage strengths in 10-count blister packs. First Previous 211 212 213 214 215 Next Last